Ampio pharmaceuticals, inc. to join the russell 2000® index and russell 3000® index

Englewood, colo., june 18, 2021 /prnewswire/ – ampio pharmaceuticals (nyse american: ampe), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced that the company is expected to join the small cap  russell 2000 ® index and the broad-market russell 3000 ® index at the conclusion of this year's reconstitution of the russell stock indexes, effective after the u.s. stock market opens on monday, june 28, 2021, accordingly to a preliminary list of additions posted on june 4, 2021.
AMPE Ratings Summary
AMPE Quant Ranking